| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Laboratory for Neurodegenerative and Aging Research, Section of Gerontology, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, MA.
Address correspondence and reprint requests to Dr. Changiz Geula, Laboratory for Neurodegenerative and Aging Research, Beth Israel Deaconess Medical Center, 21-27 Burlington Avenue, PO Box 15709, Boston, MA 02215.
Abstract.
Severe pathology in Alzheimer's disease (AD) results in marked disruption of cortical circuitry. Formation of neurofibrillary tangles, neuronal loss, decrease in dendritic extent, and synaptic depletion combine to halt communication among various cortical areas, resulting in anatomic isolation and fragmentation of many cortical zones. The clinical manifestation of this disruption is severe and debilitating cognitive dysfunction, often accompanied by psychiatric and behavioral disturbances and a diminished ability to perform activities of daily living. However, different cortical circuits are not equally vulnerable to AD pathology. In particular, two cortical systems that appear to be involved in the neural processing of memory are selectively vulnerable to degeneration in AD. One consists of connections between the hippocampus and its neighboring cortical structures within the temporal lobe. The second is the cortical cholinergic system that originates in neurons within the basal forebrain and innervates the entire cortical mantle. The circuitry in these systems shows early and severe degenerative changes in the course of AD. The selective vulnerability of these circuits is the probable reason for the early and marked loss of memory observed in these patients. This review presents current knowledge of the general pattern of cortical circuitry, followed by a summary of abnormalities of this circuitry in AD. The cortical circuits the exhibit selective pathology in AD are described in greater detail. Therapeutic implications of the abnormal circuitry in AD are also discussed. For therapies to be effective, early diagnosis of AD is necessary. Future efforts at AD therapy must be combined with an equally intense effort to develop tools capable of early diagnosis of AD, preferably at a preclinical stage before the onset of cognitive symptoms.
This article has been cited by other articles:
|
|
 |
|
  L. Ma, M. A. Seager, M. Wittmann, M. Jacobson, D. Bickel, M. Burno, K. Jones, V. K. Graufelds, G. Xu, M. Pearson, et al. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation PNAS, September 15, 2009; 106(37): 15950 - 15955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tangwongchai, N. Thavichachart, V. Senanarong, N. Poungvarin, K. Phanthumchinda, R. Praditsuwan, S. Nidhinandana, and S. Chankrachang Galantamine for the Treatment of BPSD in Thai Patients With Possible Alzheimer's Disease With or Without Cerebrovascular Disease American Journal of Alzheimer's Disease and Other Dementias, January 1, 2009; 23(6): 593 - 601. [Abstract] [PDF]
|
|
|
|
 |
|
 J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Garzon and M. Fahnestock Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells J. Neurosci., March 7, 2007; 27(10): 2628 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aracava, E. F. R. Pereira, A. Maelicke, and E. X. Albuquerque Memantine Blocks {alpha}7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1195 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G A Marshall, D I Kaufer, O L Lopez, G R Rao, R L Hamilton, and S T DeKosky Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1396 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Falke, J. Nissanov, T. W. Mitchell, D. A. Bennett, J. Q. Trojanowski, and S. E. Arnold Subicular Dendritic Arborization in Alzheimer's Disease Correlates with Neurofibrillary Tangle Density Am. J. Pathol., October 1, 2003; 163(4): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Lindeboom, B Schmand, L Tulner, G Walstra, and C Jonker Visual association test to detect early dementia of the Alzheimer type J. Neurol. Neurosurg. Psychiatry, August 1, 2002; 73(2): 126 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]
|
|
|
|
|
|
M. F. DeFreitas, P. S. McQuillen, and C. J. Shatz A Novel p75NTR Signaling Pathway Promotes Survival, Not Death, of Immunopurified Neocortical Subplate Neurons J. Neurosci., July 15, 2001; 21(14): 5121 - 5129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Phinney, T. Deller, M. Stalder, M. E. Calhoun, M. Frotscher, B. Sommer, M. Staufenbiel, and M. Jucker Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice J. Neurosci., October 1, 1999; 19(19): 8552 - 8559. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
